SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.
about
State of Art of Cancer Pharmacogenomics in Latin American Populations.HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer.Genetic variation: effect on prostate cancer.Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review.Molecular basis for prostate cancer racial disparities.Association of Polymorphisms in the VDR, CYP17 and SRD5A2 Genes and Prostate Cancer Among Lebanese MenAndrogen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese MenPolymorphisms of HPC2/ELAC2 and SRD5A2 (5α-Reductase Type II) Genes in Prostate Cancer.Association of metals and proteasome activity in erythrocytes of prostate cancer patients and controls.Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.Polymorphism of cytochrome P450 2B6 and prostate cancer risk: a significant association in a Japanese population.
P2860
Q33838298-05526FDC-C1EA-4AFF-9C49-49D5F4FA812CQ34320612-329DF870-09FC-4665-B8CF-306B615013B9Q34663656-CDD0D703-7323-4CE8-A722-ADAB3006E828Q36758880-9D765891-FDCE-4B3E-83BE-2B0D4EAF4ECAQ37633264-D3573975-D43C-4D3A-BBE1-6F52AFE91E4CQ41334556-84D4B85A-A196-4364-8F83-242B24F0E778Q41461592-0B34A217-B605-4137-B214-93F40B0E56E4Q41884768-F8BF63C1-BE5F-471B-B4B3-5643891FF804Q42074129-453E2A47-9713-458A-B1B6-997B57325E0CQ42161777-7F85606A-94C2-41EE-9F29-4421678E0F86Q43595675-09CCAB2B-1813-4F2C-9615-159D96BD4CDEQ47853637-97E4D5EA-E933-475C-A8B1-119B6507CB6D
P2860
SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
SRD5A2 and HSD3B2 polymorphism ...... ancer risk and aggressiveness.
@ast
SRD5A2 and HSD3B2 polymorphism ...... ancer risk and aggressiveness.
@en
type
label
SRD5A2 and HSD3B2 polymorphism ...... ancer risk and aggressiveness.
@ast
SRD5A2 and HSD3B2 polymorphism ...... ancer risk and aggressiveness.
@en
prefLabel
SRD5A2 and HSD3B2 polymorphism ...... ancer risk and aggressiveness.
@ast
SRD5A2 and HSD3B2 polymorphism ...... ancer risk and aggressiveness.
@en
P2093
P2860
P50
P356
P1433
P1476
SRD5A2 and HSD3B2 polymorphism ...... cancer risk and aggressiveness
@en
P2093
Benjamin A Rybicki
Christine Neslund-Dudas
Deliang Tang
James J Yang
Kristin Monaghan
P2860
P304
P356
10.1002/PROS.20625
P577
2007-11-01T00:00:00Z